Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

Jia Jie Biomedical Co., Ltd. (4109) Stock Price & Analysis

4109 Stock Chart & Stats

NT$10.10-NT$0.15(-1.46%)
At close: 12:30 AM EST
TWD 10TWD 10.5TWD 11Aug 10Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2
Day’s Range
TWD 9.63 - TWD 10.55
52-Week Range
TWD 9.63 - TWD 16.90
Previous Close
TWD 10.25
Volume
N/A
Average Volume (3M)
122.74K
Market Cap
TWD 1.20B
Enterprise Value
TWD 968.80M
Total Cash (Recent Filing)
TWD 500.33M
Total Debt (Recent Filing)
TWD 87.85M
Price to Earnings (P/E)
255.0
Beta
0.37
Next Earnings
Nov 17, 2026 (Est.)
EPS Estimate
N/A
Last Dividend Ex-Date
Sep 23, 2026
Dividend Yield
1.98%

Bulls Say, Bears Say

Bulls Say

Conservative Balance Sheet

Very low leverage and substantial equity growth provide financial resilience and reduce dependence on borrowing. This supports the company’s ability to withstand operating volatility, preserve strategic flexibility, and fund future needs without creating significant interest or refinancing pressure.

Strong Revenue Growth

Rapid revenue expansion indicates strong recent demand or business development and provides a larger base from which the company can build future earnings. If sustained, this growth can improve scale, strengthen market reach, and support continued investment in the business.

Stable Gross Margin

Maintaining a broadly stable gross margin while revenue grows suggests the company has preserved basic economics during expansion. That consistency can support operating leverage over time, provided overhead and other operating costs are controlled as the business scales.

Bears Say

Weak Cash Conversion

Weak conversion of reported earnings into operating cash reduces confidence in earnings quality and limits internally generated funding. Negative free cash flow in 2025 also suggests that spending or working-capital demands may continue to absorb cash, weakening financial flexibility.

Volatile Operating Profitability

The sharp deterioration in operating profitability indicates that recent earnings may not represent a durable level of core business performance. Continued volatility could limit predictability, reduce the benefit of revenue growth, and make long-term planning and capital allocation more difficult.

Weak Returns On Equity

A very low and inconsistent return on equity indicates that the company is not consistently converting its growing capital base into attractive profits. Unless returns improve, equity accumulation may provide resilience without producing corresponding gains in operating efficiency or shareholder value.

4109 FAQ

What was Jia Jie Biomedical Co., Ltd.’s price range in the past 12 months?
Jia Jie Biomedical Co., Ltd. lowest stock price was TWD 9.63 and its highest was TWD 16.90 in the past 12 months.
What is Jia Jie Biomedical Co., Ltd.’s market cap?
Jia Jie Biomedical Co., Ltd.’s market cap is TWD 1.20B.
When is Jia Jie Biomedical Co., Ltd.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Jia Jie Biomedical Co., Ltd.’s earnings last quarter?
Jia Jie Biomedical Co., Ltd. released its earnings results on Aug 04, 2026. The company reported -TWD 0.445 earnings per share for the quarter.
Is Jia Jie Biomedical Co., Ltd. overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Jia Jie Biomedical Co., Ltd. pay dividends?
Jia Jie Biomedical Co., Ltd. pays a ― dividend of TWD 0.2 which represents an annual dividend yield of 1.98%. See more information on Jia Jie Biomedical Co., Ltd. dividends here
What is Jia Jie Biomedical Co., Ltd.’s EPS estimate?
Jia Jie Biomedical Co., Ltd.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Jia Jie Biomedical Co., Ltd. have?
Jia Jie Biomedical Co., Ltd. has 118,736,680 shares outstanding.
What happened to Jia Jie Biomedical Co., Ltd.’s price movement after its last earnings report?
Jia Jie Biomedical Co., Ltd. reported an EPS of -TWD 0.445 in its last earnings report. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of Jia Jie Biomedical Co., Ltd.?
Currently, no hedge funds are holding shares in TW:4109
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology